Bespoke Extracts (BSPK) Amortization of Deferred Charges (2023 - 2025)
Bespoke Extracts (BSPK) reported Amortization of Deferred Charges of $10508.0 for Q3 2025, down 39.42% on a YoY basis from $17345.0 in Q3 2024, and up 2.52% sequentially from $10250.0 in Q2 2025.
Bespoke Extracts (BSPK) Amortization of Deferred Charges (2023 - 2025) Analysis & Trends
Bespoke Extracts (BSPK) has 3 years of Amortization of Deferred Charges data on file, last reported at $10508.0 in Q3 2025.
- For the quarter ending Q3 2025, Amortization of Deferred Charges fell 39.42% year-over-year to $10508.0; the trailing twelve-month figure through Sep 2025 stood at $48273.0 (down 29.4% YoY), and the FY2024 full-year result was $69053.0, up 4.04% from the prior year.
- Amortization of Deferred Charges climbed to $10508.0 in Q3 2025, from $10250.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $17517.0 in Q4 2024 to a low of $9998.0 in Q1 2025.
- A 3-year average of $14813.4 and a median of $16839.0 in 2023 frame the typical range for Amortization of Deferred Charges.
- Across the five-year window, Amortization of Deferred Charges climbed 4.03% in 2024 and plunged 41.21% in 2025, its largest moves.
- Tracing BSPK's Amortization of Deferred Charges over 3 years: stood at $16839.0 in 2023, then gained by 4.03% to $17517.0 in 2024, then plunged by 40.01% to $10508.0 in 2025.
- Business Quant data shows BSPK's Amortization of Deferred Charges at $10508.0 in Q3 2025, $10250.0 in Q2 2025, and $9998.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.88 Bn | 87.01 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn |
| 3 | Zoetis | 32.31 Bn | 30.37 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - |
| 7 | Viatris | 20.27 Bn | 18.47 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.92 Bn | 16.61 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 10,508.00 |
| Sep 30, 2025 | 10,508.00 |
| Jun 30, 2025 | 10,250.00 |
| Jun 30, 2025 | 10,250.00 |
| Mar 31, 2025 | 9,998.00 |
| Mar 31, 2025 | 9,998.00 |
| Dec 31, 2024 | 17,517.00 |
| Dec 31, 2024 | 17,517.00 |
| Sep 30, 2024 | 17,345.00 |
| Sep 30, 2024 | 17,345.00 |
| Jun 30, 2024 | 17,185.00 |
| Jun 30, 2024 | 17,185.00 |
| Mar 31, 2024 | 17,006.00 |
| Mar 31, 2024 | 17,006.00 |
| Dec 31, 2023 | 16,839.00 |
| Dec 31, 2023 | 16,839.00 |
| Sep 30, 2023 | 16,673.00 |
| Sep 30, 2023 | 16,673.00 |